Emergent Biosolutions Inc.
$694.50M- Market cap
- $310.20M
- Debt
- +$589.70M
- Cash
- −$205.40M
Capital structure 34% equity / 66% debt · EV / Revenue 0.93x · EV / EBITDA 2.92x
Quick read
Fair value engine
Each company valued on the other's multiple, then compared with the market price.
EBS · current priceP/E 6.51x
$6.05Latest market snapshot
Implied fair value · at CART's multiple
$28.31367.9% above market
0.93 EBS EPS (TTM)×30.44x CART P/E=$28.31
Market $6.05Implied $28.31
CART · current priceP/E 30.44x
$48.70Latest market snapshot
Implied fair value · at EBS's multiple
$10.4178.6% below market
1.60 CART EPS (TTM)×6.51x EBS P/E=$10.41
Market $48.70Implied $10.41